Literature DB >> 17009068

The prevalence of venous insufficiency in patients with chronic obstructive pulmonary disease evaluated by color duplex ultrasonography.

Besir Erdogmus1, Ali Nihat Annakkaya, Burhan Yazici, Ismet Bulut, Betul Ayca Ozdere, Ramazan Buyukkaya.   

Abstract

OBJECTIVES: We hypothesized that in patients with chronic obstructive pulmonary disease (COPD) some extrapulmonary effects such as increase in intra-abdominal and intra-thoracic pressures, presence of cor pulmonale and pulmonary artery hypertension could cause venous insufficiency (VI) in the lower limbs. Our aim in this study was to assess the prevalence of VI in patients with COPD in comparison with healthy controls.
METHODS: Thirty-nine male patients with COPD and 36 healthy male controls were evaluated for VI. All the participants were in the same age group and their smoking intensities were similar. Patients with COPD were classified as having mild, moderate, severe or very severe disease according to criteria of the Global Initiative for Chronic Obstructive Lung Disease. All the patients and control group were examined for unilateral or bilateral VI of the common femoral vein, superficial femoral vein, deep femoral vein and popliteal vein using color duplex ultrasonography.
RESULTS: The prevalence of VI of the lower extremity in patients with COPD (69.2%) was significantly higher than in the healthy control group (41.7%). The prevalence increased as the COPD severity increased and VI was detected in all the patients with very severe COPD [mild COPD, 50.0% (2/4); moderate, 58.8% (10/17); severe, 75.0% (9/12); very severe, 100% (6/6)].
CONCLUSION: VI of the lower extremity appears more frequent in patients with COPD. We suggest ruling out COPD in patients with otherwise unexplained "primary" VI.

Entities:  

Mesh:

Year:  2006        PMID: 17009068     DOI: 10.1007/s00508-006-0660-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  20 in total

Review 1.  Chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

Review 2.  [Pulmonary hypertension and cor pulmonale in COPD].

Authors:  Ichiro Kuwahira; Tokuzen Iwamoto
Journal:  Nihon Rinsho       Date:  2003-12

Review 3.  [Pursed lips breathing].

Authors:  G A de F Fregonezi; V R Resqueti; R Güell Rous
Journal:  Arch Bronconeumol       Date:  2004-06       Impact factor: 4.872

4.  Varicose veins, deep vein thrombosis, and haemorrhoids: epidemiology and suggested aetiology.

Authors:  D P Burkitt
Journal:  Br Med J       Date:  1972-06-03

5.  Pulmonary thromboembolism.

Authors:  S Filipecki; J Kober; D Kaminski; W Tomkowski
Journal:  Monaldi Arch Chest Dis       Date:  1997-10

Review 6.  [Causal proceeding in chronic obstructive pulmonary disease].

Authors:  Andrzej Chciałowski; Wojciech Lubiński
Journal:  Pol Merkur Lekarski       Date:  2004-05

Review 7.  Intrinsic PEEP and cardiopulmonary interaction in patients with COPD and acute ventilatory failure.

Authors:  V M Ranieri; M Dambrosio; N Brienza
Journal:  Eur Respir J       Date:  1996-06       Impact factor: 16.671

8.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

Authors:  A M Schols; J Slangen; L Volovics; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

9.  In vivo effects of theophylline on diaphragm, bicep, and quadricep strength and fatigability.

Authors:  C DeGarmo; F Cerny; K Conboy; E F Ellis
Journal:  J Allergy Clin Immunol       Date:  1988-12       Impact factor: 10.793

10.  Venous reflux in symptom-free vascular surgeons.

Authors:  N Labropoulos; K T Delis; A N Nicolaides
Journal:  J Vasc Surg       Date:  1995-08       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.